By Dr Richard Kevin

Journal articles

Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL, 2017, 'Thermolytic degradation of synthetic cannabinoids: Chemical exposures and pharmacological consequences', Journal of Pharmacology and Experimental Therapeutics, 361, pp. 162 - 171, http://dx.doi.org/10.1124/jpet.116.238717

Kevin RC; Allsop DJ; Lintzeris N; Dunlop AJ; Booth J; McGregor IS, 2017, 'Urinary cannabinoid levels during nabiximols (Sativex^®)-medicated inpatient cannabis withdrawal', Forensic Toxicology, 35, pp. 33 - 44, http://dx.doi.org/10.1007/s11419-016-0330-0

Lefever TW; Marusich JA; Thomas BF; Barrus DG; Peiper NC; Kevin RC; Wiley JL, 2017, 'Vaping synthetic cannabinoids: A novel preclinical model of E-cigarette use in mice', Substance Abuse: Research and Treatment, 11, http://dx.doi.org/10.1177/1178221817701739

Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JBC; Glass M; McGregor IS; Connor M; Kassiou M, 2016, 'Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues', ACS Chemical Neuroscience, 7, pp. 1241 - 1254, http://dx.doi.org/10.1021/acschemneuro.6b00137

Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135', ACS Chemical Neuroscience, 6, pp. 1445 - 1458, http://dx.doi.org/10.1021/acschemneuro.5b00107

Banister SD; Stuart J; Conroy T; Longworth M; Manohar M; Beinat C; Wilkinson SM; Kevin RC; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues', Forensic Toxicology, 33, pp. 355 - 366, http://dx.doi.org/10.1007/s11419-015-0282-9

Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M, 2015, 'Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA', ACS Chemical Neuroscience, 6, pp. 1546 - 1559, http://dx.doi.org/10.1021/acschemneuro.5b00112

Ramos L; Hicks C; Kevin R; Caminer A; Narlawar R; Kassiou M; McGregor IS, 2013, 'Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: Involvement of the V1 a receptor', Neuropsychopharmacology, 38, pp. 2249 - 2259, http://dx.doi.org/10.1038/npp.2013.125

Bowen MT; Kevin RC; May M; Staples LG; Hunt GE; McGregor IS, 2013, 'Defensive Aggregation (Huddling) in Rattus Norvegicus toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0068483

Conference Papers

Banister S; Longworth M; Stuart J; Kevin R; Glass M; Gerona R; Connor M; Mcgregor I; Kassiou M, 2016, 'Evolution of synthetic cannabinoid designer drugs', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431905703424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Lintzeris N; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Nghi P; Montebello M; Chan T; Kirby A; Hall M; Bhardwaj A; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'EFFICACY OF NABIXIMOLS IN REDUCING FREQUENCY OF CANNABIS USE THREE MONTHS AFTER TREATMENT CESSATION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S66 - S67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Allsop D; Bhardwaj A; Mills L; Dunlop AJ; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza MJ; Shanahan M; Kevin R, 2018, 'FINDINGS OF A PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIAL OF NABIXIMOLS IN THE TREATMENT OF CANNABIS DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S45 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR, 2018, The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogues, http://dx.doi.org/10.1101/430959

Back to profile page